Pure Health Holding PJSC

ADX:PUREHEALTH Stock Report

Market Cap: د.إ32.3b

Pure Health Holding PJSC Valuation

Is PUREHEALTH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PUREHEALTH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
د.إ3.27
Fair Value
11.0% undervalued intrinsic discount
4
Number of Analysts

Below Fair Value: PUREHEALTH (AED2.91) is trading below our estimate of fair value (AED3.27)

Significantly Below Fair Value: PUREHEALTH is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PUREHEALTH?

Key metric: As PUREHEALTH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for PUREHEALTH. This is calculated by dividing PUREHEALTH's market cap by their current earnings.
What is PUREHEALTH's PE Ratio?
PE Ratio18.9x
Earningsد.إ1.71b
Market Capد.إ32.33b

Price to Earnings Ratio vs Peers

How does PUREHEALTH's PE Ratio compare to its peers?

The above table shows the PE ratio for PUREHEALTH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.6x
BURJEEL Burjeel Holdings
22x41.7%د.إ7.7b
GMPC Gulf Medical Projects Company (PJSC)
18.4xn/aد.إ1.4b
EHC Encompass Health
21.5x8.6%US$9.8b
ENSG Ensign Group
24.5x12.5%US$7.3b
PUREHEALTH Pure Health Holding PJSC
18.9x20.9%د.إ32.3b

Price-To-Earnings vs Peers: PUREHEALTH is good value based on its Price-To-Earnings Ratio (18.9x) compared to the peer average (21.6x).

Price to Earnings Ratio vs Industry

How does PUREHEALTH's PE Ratio compare vs other companies in the Asian Healthcare Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
PUREHEALTH 18.9xIndustry Avg. 20.5xNo. of Companies50PE01632486480+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: PUREHEALTH is good value based on its Price-To-Earnings Ratio (18.9x) compared to the Asian Healthcare industry average (20.6x).

Price to Earnings Ratio vs Fair Ratio

What is PUREHEALTH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PUREHEALTH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio18.9x
Fair PE Ratio17.4x

Price-To-Earnings vs Fair Ratio: PUREHEALTH is expensive based on its Price-To-Earnings Ratio (18.9x) compared to the estimated Fair Price-To-Earnings Ratio (17.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PUREHEALTH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentد.إ2.91
د.إ4.95
+70.0%
22.8%د.إ6.10د.إ3.80n/a4
Mar ’26د.إ3.16
د.إ4.95
+56.6%
22.8%د.إ6.10د.إ3.80n/a4
Feb ’26د.إ3.52
د.إ5.33
+51.4%
19.8%د.إ6.10د.إ3.84n/a3
Jan ’26د.إ3.33
د.إ6.08
+82.4%
0.4%د.إ6.10د.إ6.05n/a2
Dec ’25د.إ3.28
د.إ6.08
+85.2%
0.4%د.إ6.10د.إ6.05n/a2
Nov ’25د.إ3.44
د.إ6.08
+76.6%
0.4%د.إ6.10د.إ6.05n/a2
Oct ’25د.إ3.53
د.إ6.08
+72.1%
0.4%د.إ6.10د.إ6.05n/a2
Sep ’25د.إ3.65
د.إ6.08
+66.4%
0.4%د.إ6.10د.إ6.05n/a2
Analyst Price Target
Consensus Narrative from 4 Analysts
د.إ4.95
Fair Value
41.2% undervalued intrinsic discount
4
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/22 21:11
End of Day Share Price 2025/03/21 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pure Health Holding PJSC is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christine KalindjianArqaam Capital Research Offshore S.A.L.
Raj SinhaHSBC